| Bioactivity | Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
| Name | Oritavancin |
| CAS | 171099-57-3 |
| Formula | C86H97Cl3N10O26 |
| Molar Mass | 1793.10 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Coyle EA, et al. Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2001 Mar;45(3):706-9. [2]. Arhin FF, et al. Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing. Antimicrob Agents Chemother. 2008 May;52(5):1597-603. |
Oritavancin
CAS: 171099-57-3 F: C86H97Cl3N10O26 W: 1793.10
Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Orita
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.